Stock News

Tributary Capital Management Decreased By $420,000 Its Bio Techne (TECH) Stake; Synalloy (SYNL) Has 1 Sentiment

Synalloy Corporation engages in production and sale of stainless steel pipes, fiberglass, steel storage tanks, and specialty chemicals in the United States and internationally. The company has market cap of $126.56 million. The firm operates in two divisions, Metals and Specialty Chemicals. It currently has negative earnings. The Metals segment makes and sells stainless steel and other alloy pipes under the BRISMET trade name through authorized stocking distributors; and liquid storage solutions and separation equipment, as well as distributes seamless carbon pipes and tubes.

Tributary Capital Management Llc decreased Bio Techne Corp (TECH) stake by 20.35% reported in 2017Q3 SEC filing. Tributary Capital Management Llc sold 3,500 shares as Bio Techne Corp (TECH)’s stock rose 4.48%. The Tributary Capital Management Llc holds 13,700 shares with $1.66 million value, down from 17,200 last quarter. Bio Techne Corp now has $5.32 billion valuation. The stock increased 1.78% or $2.49 during the last trading session, reaching $141.99. About 166,253 shares traded. Bio-Techne Corporation (NASDAQ:TECH) has risen 6.75% since February 25, 2017 and is uptrending. It has underperformed by 9.95% the S&P500.

Among 9 analysts covering BIO-TECHNE Corp (NASDAQ:TECH), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. BIO-TECHNE Corp had 22 analyst reports since August 18, 2015 according to SRatingsIntel. On Monday, March 27 the stock rating was downgraded by Janney Capital to “Neutral”. As per Thursday, November 10, the company rating was reinitiated by Leerink Swann. The stock has “Hold” rating by Zacks on Tuesday, September 22. Stephens downgraded the stock to “Equal-Weight” rating in Thursday, October 29 report. The stock of Bio-Techne Corporation (NASDAQ:TECH) earned “Buy” rating by Robert W. Baird on Tuesday, October 31. Stephens maintained the stock with “Hold” rating in Wednesday, February 7 report. Deutsche Bank maintained the shares of TECH in report on Wednesday, August 9 with “Buy” rating. Citigroup initiated it with “Buy” rating and $115 target in Thursday, February 9 report. The rating was maintained by Robert W. Baird on Monday, October 23 with “Buy”. The company was upgraded on Tuesday, May 3 by Janney Capital.

Since September 6, 2017, it had 0 insider buys, and 4 sales for $833,502 activity. HOLBROOK KAREN A sold 1,059 shares worth $128,909. Another trade for 100 shares valued at $12,094 was made by LUCAS ROGER C on Friday, September 8. On Tuesday, February 13 Dinarello Charles A sold $680,303 worth of Bio-Techne Corporation (NASDAQ:TECH) or 5,000 shares.

Analysts await Bio-Techne Corporation (NASDAQ:TECH) to report earnings on May, 1. They expect $1.07 earnings per share, up 20.22% or $0.18 from last year’s $0.89 per share. TECH’s profit will be $40.10M for 33.18 P/E if the $1.07 EPS becomes a reality. After $0.91 actual earnings per share reported by Bio-Techne Corporation for the previous quarter, Wall Street now forecasts 17.58% EPS growth.

Investors sentiment decreased to 1.21 in Q3 2017. Its down 0.23, from 1.44 in 2017Q2. It dived, as 16 investors sold TECH shares while 86 reduced holdings. 36 funds opened positions while 87 raised stakes. 35.91 million shares or 2.04% less from 36.66 million shares in 2017Q2 were reported. Lpl Financial Limited Liability Com has 2,546 shares for 0% of their portfolio. Jpmorgan Chase & Com reported 1,227 shares stake. Manitoba – Canada-based Ig Investment Mngmt Ltd has invested 0.01% in Bio-Techne Corporation (NASDAQ:TECH). Barclays Public Ltd reported 29,265 shares. Granite Prtn Limited Liability Com invested 0.12% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Gotham Asset Mgmt Ltd Liability has invested 0.05% in Bio-Techne Corporation (NASDAQ:TECH). Credit Suisse Ag holds 0.01% in Bio-Techne Corporation (NASDAQ:TECH) or 44,760 shares. Ubs Asset Mngmt Americas Inc invested 0% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Eagle Asset accumulated 55,995 shares or 0.04% of the stock. Illinois-based Nuveen Asset Management Ltd Llc has invested 0% in Bio-Techne Corporation (NASDAQ:TECH). Stephens Investment Gp Lc invested in 0.29% or 102,550 shares. Alliancebernstein Lp stated it has 25,754 shares or 0% of all its holdings. Metropolitan Life Insurance Com Ny invested 0.03% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). 7,306 are owned by Bessemer Incorporated. Commonwealth Of Pennsylvania Public School Empls Retrmt owns 5,446 shares or 0.01% of their US portfolio.

Tributary Capital Management Llc increased Expedia Inc (NASDAQ:EXPE) stake by 8,000 shares to 13,500 valued at $1.94M in 2017Q3. It also upped Marcus & Millichap Inc (NYSE:MMI) stake by 49,425 shares and now owns 558,106 shares. Almost Family Inc (NASDAQ:AFAM) was raised too.

The stock increased 4.69% or $0.65 during the last trading session, reaching $14.5. About 13,200 shares traded or 46.73% up from the average. Synalloy Corporation (SYNL) has risen 59.68% since February 25, 2017 and is uptrending. It has outperformed by 42.98% the S&P500.

Leave a Reply

Your email address will not be published. Required fields are marked *